New pill could reduce blood draws for rare blood cancer patients
NCT ID NCT05558696
First seen May 08, 2026 · Last updated May 08, 2026
Summary
This study tested an experimental pill called bomedemstat in 20 adults with polycythemia vera, a rare blood cancer that causes too many red blood cells. The goal was to see if the drug could safely lower red blood cell levels without needing frequent blood removal (phlebotomy). Participants who benefited could continue treatment for up to a year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYTHEMIA VERA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BRCR Global ( Site 0120)
Plantation, Florida, 33322, United States
-
Boston Pilgrim Hospital ( Site 0207)
Boston, Lincolnshire, PE21 9QS, United Kingdom
-
Comprehensive Cancer Centers of Nevada - Peak ( Site 0118)
Las Vegas, Nevada, 89128, United States
-
Duke University Medical Center ( Site 0016)
Durham, North Carolina, 27705, United States
-
Gloucestershire Royal Hospital ( Site 0205)
Gloucester, England, GL1 3NN, United Kingdom
-
Guys and St Thomas NHS Foundation Trust - Guys Hospital ( Site 0020)
London, London, City of, SE1 9RT, United Kingdom
-
Hematology Oncology of the North Shore ( Site 0104)
Skokie, Illinois, 60076-1264, United States
-
Huntsman Cancer Hospital at the University of Utah ( Site 0119)
Salt Lake City, Utah, 84112, United States
-
Imperial College London ( Site 0025)
London, Great Britain, W12 0HS, United Kingdom
-
Monash Medical Centre ( Site 0006)
Clayton, Victoria, 3168, Australia
-
OHSU Knight Cardiovascular Institute Cardiology Clinic - South Waterfront ( Site 0102)
Portland, Oregon, 97239-4503, United States
-
Ohio State University Comprehensive Cancer Center ( Site 0103)
Columbus, Ohio, 43203, United States
-
Royal Gwent Hospital ( Site 0201)
Newport, Wales, NP9 2UB, United Kingdom
-
Royal Perth Hospital ( Site 0504)
Perth, Western Australia, 6000, Australia
-
Sunshine Coast Hematology and Oncology Clinic (Site 0506)
Sunshine Coast, Queensland, 4556, Australia
-
United Lincolnshire Hospitals NHS Trust ( Site 0204)
Lincoln, Great Britain, LN2 5QY, United Kingdom
-
University of Michigan Comprehensive Cancer Center ( Site 0008)
Ann Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.